These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34666508)

  • 1. Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial.
    Dai L; Xu J; Yan H; Chen Z; Pan Y; Meng X; Li H; Wang Y
    Stroke; 2022 Feb; 53(2):465-472. PubMed ID: 34666508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
    Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
    Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
    Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
    JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score.
    Angiolillo DJ; Capodanno D; Danchin N; Simon T; Bergmeijer TO; Ten Berg JM; Sibbing D; Price MJ
    JACC Cardiovasc Interv; 2020 Mar; 13(5):606-617. PubMed ID: 32139218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
    JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor Aspirin vs Clopidogrel Aspirin in
    Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
    Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile.
    Xu J; Wang A; Wangqin R; Mo J; Chen Z; Dai L; Meng X; Zhao X; Wang Y; Li H; Chen W; Xian Y; Wang Y;
    Ann Neurol; 2019 Sep; 86(3):419-426. PubMed ID: 31237713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
    Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
    Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Clopidogrel for Prevention of Stroke Based on
    Meschia JF; Walton RL; Farrugia LP; Ross OA; Elm JJ; Farrant M; Meurer WJ; Lindblad AS; Barsan W; Ching M; Gentile N; Ross M; Nahab F; Easton JD; Kim AS; Zurita KG; Cucchiara B; Johnston SC
    Stroke; 2020 Jul; 51(7):2058-2065. PubMed ID: 32568642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
    BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With
    Lin Y; Wang A; Li J; Lin J; Wang D; Meng X; Ou L; Chen W; Zhao X; Liu L; Wang Y; Wang Y;
    Stroke; 2017 Apr; 48(4):998-1004. PubMed ID: 28289237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
    Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
    Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
    Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
    Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
    Wang A; Meng X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang F; Li Y; Liu J; Wang Y;
    Ann Neurol; 2022 Mar; 91(3):380-388. PubMed ID: 34951042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke Recurrence and Antiplatelets in Posterior Versus Anterior Circulation Minor Stroke or Transient Ischemic Attack.
    Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
    Stroke; 2023 Apr; 54(4):964-972. PubMed ID: 36789773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
    Zhou Y; Pan Y; Wu Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Wang C; Meng X; Wang Y; Wang Y;
    Stroke; 2016 Nov; 47(11):2791-2796. PubMed ID: 27738237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients.
    Ma Y; Liu Y; Xu J; Wang Y; Du F; Wang Y
    J Clin Hypertens (Greenwich); 2019 May; 21(5):598-604. PubMed ID: 30957391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.